Clinical Trial Update: Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fractionated versus target-controlled propofol administration during bronchoscopy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Pneumonia
• Lung Cancer
• Sarcoidosis

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: Daniel Franzen | Conditions: Lung Cancer, Sarcoidosis | Phase 4 | Status: COMPLETED